Chemed Corp. (CHE) Tops Q3 EPS by 10c; Guides Strong FY11 EPS
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Join SI Premium – FREE
Chemed Corp. (NYSE: CHE) reported Q3 EPS of $1.20, $0.10 better than the analyst estimate of $1.10. Revenue for the quarter came in at $341 million versus the consensus estimate of $342.92 million.
Chemed Corp. sees FY2011 EPS of $4.75-$4.85, versus the consensus of $4.31.
Chemed Corp. sees FY2011 EPS of $4.75-$4.85, versus the consensus of $4.31.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
